Lia Gore, MD
Professor, Department of Pediatrics, Section of Hematology-Oncology
Children’s Hospital Colorado/University of Colorado School of Medicine
Dr. Gore’s research interests are focused on the development of novel cancer therapeutics with a particular emphasis on pediatric and hematological malignancies. She has been a PI or co-PI on more than 200 national and international clinical trials and serve on advisory panels to the Oncology Drug Advisory Committee (ODAC) to the US FDA, serves on the Developmental Therapeutics Study Section of the NCI/NIH, and has advised at the European Medicines Agency. Her research has focused on particularly high-risk diseases such as relapsed leukemia, sarcoma, and CNS tumors refractory to conventional therapies. She currently serves as co-Director of the Hematological Malignancies Program at the University of Colorado NCI-designated Comprehensive Cancer Center and the Section Head for Pediatric Hematology/Oncology/Bone Marrow Transplant, and is part of the Executive Committee for ALL in the Children’s Oncology Group. Dr. Gore is an enthusiastic collaborator with her colleagues world-wide who share the goal of bettering the treatment and outcomes for children with cancer.